Program Objectives, MCRC Project 2
Objectives of the Clinical Lupus Research Program
• Develop clinical research program to understand and improve outcomes in patients with lupus
• Provide outstanding clinical care for patients with lupus including new treatment options
• Train the next generation of young investigators to continue the drive for the cure of this disease
• Collaborate with basic scientists to uncover the cause of lupus and to discover new treatments
Focus Areas for Clinical Lupus Research Program
• Assess risk of cancer, osteoporosis, and cardiovascular complications in SLE
• Continue national & international collaborations studying genetic risk factors for disease susceptibility & severity in SLE
• Participate in discovery of biomarkers
• Design, monitor & perform clinical trials testing innovative therapies in SLE
This project within our ongoing MCRC heavily involves the MCRC Epidemiology Program, Epidemiologic Studies of Systemic Lupus Erythematosus. Program members and collaborators are shown in Table 1.
| Epidemiologic Studies of Systemic Lupus Erythematosus | |
| Rosalind Ramsey-Goldman MD, DrPH, Program Leader | Rheumatology |
| James Carr MD | Radiology |
| David Cella PhD | Medical Social Sciences |
| Syamal Datta MD | Rheumatology, Microbiology-Immunology |
| Dorothy Dunlop PhD | IHS, Preventive Medicine, Rheumatology |
| Chiang-Ching (Spencer) Huang PhD | Preventive Medicine |
| Craig Langman MD | Pediatrics |
| Jungwha (Julia) Lee PhD | Preventive Medicine |
| Kiang Liu PhD | Preventive Medicine |
| William Pearce MD | Vascular Surgery |
| Richard Pope MD | Rheumatology |
| Paula Stern PhD | Molecular Pharmacology and Biological Chemistry |
| Collaborators not at NU: Elizabeth Brown PhD (UAB); Daniel Edmundiwicz MD (Temple); Robert Kimberly MD (UAB); Susan Manzi MD, MPH (WestPenn Allegheny Health System); David McPherson MD (Texas); Kim Sutton Tyrell MD (Pittsburgh); Joseph Witztum (UCSD) | |
